Developing a Patient-centered Patient Decision Aid for Psoriasis and/or Psoriatic Arthritis Using Design Thinking.
Overview
- Phase
- N/A
- Intervention
- Decision Aid
- Conditions
- Psoriatic Arthritis
- Sponsor
- University of Pennsylvania
- Enrollment
- 37
- Locations
- 1
- Primary Endpoint
- Patient and provider self-reported perceptions of the decision aid as measured by satisfaction survey
- Status
- Completed
- Last Updated
- 2 months ago
Overview
Brief Summary
The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.
Detailed Description
Prior to the interventional study, we will develop a decision aid using design thinking. In this interventional study, we will implement and test a patient-centered decision aid for therapy selection among patients with psoriasis and/or psoriatic arthritis who are starting or switching to a new medication.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18 years or older
- •Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist)
- •Treated at Penn
- •In addition to the above, for the observation and implementation phases of the study:
- •Initiation of a new psoriasis or psoriatic arthritis treatment
- •Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation
- •Patients may be taking other traditional DMARDs.
- •A washout period is not required.
Exclusion Criteria
- •Unable to give informed consent
- •Youth, under the age of 18 years
- •Patients without psoriasis or psoriatic arthritis
- •Not being treated at a Penn clinic
- •In addition to the above, for the observation and implementation phases of the study:
- •Not starting or switching to a new medication
Arms & Interventions
Decision Aid Testing
Participants will have the opportunity to test the different decision aid prototypes while selecting new treatment/therapy.
Intervention: Decision Aid
Outcomes
Primary Outcomes
Patient and provider self-reported perceptions of the decision aid as measured by satisfaction survey
Time Frame: Up to 24 months
Satisfaction survey to rate the decision aid and shared decision-making process
Secondary Outcomes
- Number of times decision aid was used in consultation for patients switching therapies or starting a new treatment.(Up to 24 months)